TheBodyPro | Expert analysis from Benjamin Young, M.D., Ph.D.
For those of us who are accustomed to seeing liver disease through a virology lens, new data from an all-women U.S. cohort provide a critical new perspective: Modern-day steatotic liver disease (SLD) is extremely common — even outside of viral hepatitis coinfection — and its relationship to HIV is more complicated than we may have previously realized.
Key Takeaways
- Steatotic liver disease prevalence was 47%, regardless of HIV status, in a cohort of U.S. women; body mass index and diabetes were major predictors.
- Among women with steatotic liver disease, HIV was associated with 48% greater adjusted odds of clinically significant fibrosis.
- It is important for HIV clinicians to assess fibrosis risk alongside metabolic factors, and resist assumptions to blame antiretroviral therapy or conclude that steatosis alone indicates significant liver disease.
Read the full analysis here.
Source : TheBodyPro
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.